Global Sepsis Diagnostics Market

Sepsis Diagnostics Market Size, Share, Growth Analysis, By Technology(Blood Culture Technology and Immunoassays), By Application(Hospitals and Diagnostics Centres), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2237 | Region: Global | Published Date: March, 2024
Pages: 219 |Tables: 59 |Figures: 75

Sepsis Diagnostics Market Insights

Global Sepsis Diagnostics Market size was valued at USD 0.67 billion in 2022 and is poised to grow from USD 0.74 billion in 2023 to USD 1.55 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031). 

the global market for sepsis diagnostic solutions is anticipated to expand rapidly in the next years, Due to a number of factors, including the high frequency rising awareness of sepsis, and the introduction of technologically sophisticated diagnostic solutions. According to data published by the World Health Organization (WHO), sepsis affects over 30 million people and causes 6 million deaths every year globally, with 3 million newborns and 1.2 million children being affected annually. The high prevalence of sepsis is expected to increase the demand for diagnostic solutions, which will drive the growth of the sepsis diagnostic market. The existing diagnostic tests for sepsis take up to 72 hours to provide final results, making the demand for rapid diagnostic tests high for early diagnosis of sepsis. In February 2019, researchers at the University of Strathclyde developed a ground-breaking and cost-effective test for earlier diagnosis of sepsis, which uses a microelectrode to analyze the patient's blood and provides final results in just two and a half minutes. Hospital-acquired infections (HAIs) can trigger sepsis, especially in the geriatric population, newborn babies, and people suffering from chronic diseases. According to the WHO, in developed countries, 7 out of every 100 hospitalized patients are likely to develop HAIs, whereas this number increases to 10 in developing countries due to poor healthcare infrastructure. Additionally, the Centers for Disease Control and Prevention (CDC) estimates that around 1.7 million patients suffer from HAIs every year, with around 99,000 patients dying due to HAIs in the US.

Market Snapshot - 2024-2031

Global Market Size

USD 0.67 billion

Largest Segment

Blood Culture Technology

Fastest Growth

Immunoassays

Growth Rate

9.8% CAGR

Global Sepsis Diagnostics Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Sepsis Diagnostics Market Segmental Analysis

Global Sepsis Diagnostics market is segmented by type, application, and region. Based on type, the market can be segmented into blood culture technology and immunoassays. Based on application, the market is segmented into hospitals and diagnostics centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Sepsis Diagnostics Market Analysis by Type

By type, the market can be segmented into blood culture technology and immunoassays. Blood Culture Technology dominated the sepsis diagnostics market, owing to its wide adoption in hospitals and diagnostic laboratories. This technology involves the culturing of blood samples in specific media to identify the presence of bacteria or fungi. The high sensitivity and specificity of this method have made it the gold standard for the diagnosis of sepsis, which has contributed to its dominance in the market.

Immunoassays segment is expected to grow at the fastest CAGR. These tests are based on the detection of antibodies or antigens in blood or other body fluids to identify the presence of infection. The advantages of immunoassays over blood culture technology include faster turnaround time, ease of use, and ability to detect infections that are difficult to culture. The increasing demand for rapid diagnostic tests and the need for early diagnosis of sepsis have contributed to the rapid growth of immunoassays in the sepsis diagnostics market.

Global Sepsis Diagnostics Market Analysis by Application

By application, the market can be segmented into hospitals and diagnostics centres. Hospitals dominate the sepsis diagnostics market, as they are the primary facilities for the diagnosis and treatment of sepsis. Hospitals typically have advanced diagnostic equipment and well-trained medical staff, enabling them to quickly and accurately diagnose sepsis and initiate treatment. Additionally, the increasing prevalence of sepsis, particularly in hospitalized patients, has further contributed to the dominance of hospitals in the sepsis diagnostics market.

Diagnostic laboratories are the fastest-growing segment in the sepsis diagnostics market. This growth can be attributed to the increasing demand for accurate and timely sepsis diagnosis, particularly in outpatient settings. Diagnostic laboratories provide diagnostic services to a wide range of healthcare providers, including hospitals, clinics, and physician offices. The increasing availability of point-of-care diagnostic tests for sepsis has also contributed to the growth of diagnostic laboratories, as they often perform confirmatory testing for these tests.

Global Sepsis Diagnostics Market Size By Technology, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Sepsis Diagnostics Market Regional Insights

North America dominated the sepsis diagnostic market due to the increasing incidence of sepsis and hospital-acquired infections, coupled with the presence of leading market players and advanced healthcare infrastructure. The US and Canada are the major contributors to the growth of the market in this region. In addition, the increasing awareness about sepsis and the availability of advanced diagnostic solutions are also driving the growth of the market in North America.

Asia Pacific is expected to witness the fastest growth in the sepsis diagnostic market. The growth in this region is attributed to the increasing prevalence of sepsis and hospital-acquired infections, rising geriatric population, increasing healthcare expenditure, and improving healthcare infrastructure. Moreover, the growing awareness about the importance of early diagnosis of sepsis and the availability of cost-effective diagnostic solutions are also driving the growth of the market in the APAC region. China, Japan, India, and Australia are the major contributors to the growth of the market in this region.

Global Sepsis Diagnostics Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Sepsis Diagnostics Market Dynamics

Drivers

Rising incidence of hospital-acquired infections

  • The increasing occurrence of hospital-acquired infections (HAIs), commonly referred to as nosocomial infections, represents a significant global health concern. Among the most prevalent HAIs are urinary tract infections, pneumonia, and sepsis. These infections can have particularly severe consequences in vulnerable patient populations, including those who are immunocompromised, elderly, or suffering from chronic illnesses. In the United States, there is a troubling trend of rising sepsis incidence among hospitalized patients, with an annual increase of 8.7%. It is estimated that the United States witnesses over 1,000,000 cases of sepsis among hospitalized patients each year, as reported by the Centers for Disease Control and Prevention (CDC) in 2018. Given the rapid escalation of HAIs on a global scale, there is a heightened demand anticipated for sepsis diagnostic products in the years ahead.

Development of rapid diagnostic/POC techniques for early sepsis diagnosis

  • The early diagnosis of sepsis presents a considerable challenge, as even a delay of just one minute in administering antibiotics to septic shock patients with hypertension can result in a 7.6% increase in mortality risk. Consequently, there is a growing imperative for the swift and accurate diagnosis of sepsis to minimize delays in antibiotic therapy for affected patients. Many manufacturers specializing in sepsis diagnostics are actively expanding their product portfolios to incorporate point-of-care (POC) technologies designed to rapidly detect sepsis, thereby reducing the overall time required for diagnosis. One such example is the BD Company (US), which offers automated microbial detection systems including the BACTEC Plus, BacT/Alert, and BACTEC FX blood culturing instruments. These instruments are engineered to facilitate the swift diagnosis of sepsis, with a turnaround time as short as three hours. This development represents a significant advancement in sepsis diagnosis, aligning with the critical need for rapid intervention in septic patients.

Improvement in Awareness in Emerging Countries to Boost Diagnostic Procedures

  • The growing prevalence of sepsis represents a significant economic and healthcare challenge, particularly in developing nations. To address this issue, various government and non-government entities are actively engaged in initiatives aimed at enhancing public awareness of this condition. These programs typically encompass activities such as sepsis screening, educational campaigns, evaluation of sepsis bundle performance, the adoption of advanced diagnostic techniques to improve patient outcomes, and the establishment of treatment protocols. An illustrative example can be found in an article published by Springer Nature Switzerland AG in October 2021, highlighting that the implementation of such programs and guidelines contributes to increased adherence to sepsis bundles and a reduction in mortality rates among affected patients. One of the notable organizations leading in this endeavor is the Global Sepsis Alliance, which has forged partnerships with various entities across different regions, including Latin America and Africa, to raise awareness about sepsis. Additionally, the World Health Organization (WHO) has collaborated with 52 countries to execute the Global Maternal Sepsis Study and Campaign (GLOSS), which seeks to assess the prevalence and management of maternal sepsis while also enhancing healthcare workers' awareness of this critical issue. Consequently, the collective efforts of government organizations and foundations to foster awareness and garner support are expected to significantly bolster the global market for sepsis diagnostics.

Restraints

High cost associated with the development and commercialization

  • One of the major restraints of the global sepsis diagnostic market is the high cost associated with the development and commercialization of advanced diagnostic solutions. Additionally, the lack of awareness among the general population about sepsis and its symptoms can hinder the market growth. Moreover, the lack of healthcare infrastructure in developing countries can limit the availability of sepsis diagnostic solutions, which can hinder market growth. Finally, the stringent regulatory framework governing the approval of diagnostic solutions can also be a challenge for manufacturers operating in the market.

 

Request Free Customization of this report to help us to meet your business objectives.

Sepsis Diagnostics Market Competitive Landscape

The global sepsis diagnostic market is highly competitive, with several established players competing for market share. These companies are investing heavily in R&D activities to develop technologically advanced diagnostic solutions and gain a competitive edge. Moreover, strategic partnerships and collaborations with other companies and healthcare facilities are commonly observed in the market. Additionally, companies are focusing on expanding their geographic presence through acquisitions, partnerships, and collaborations. Furthermore, product launches, regulatory approvals, and patent filings are among the key strategies adopted by companies to strengthen their market position.

Top Player’s Company Profiles in Global Sepsis Diagnostics Market

  • Abbott Laboratories (US)
  • Becton, Dickinson and Company (US)
  • bioMérieux SA (France)
  • Cepheid (US)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Hologic Inc. (US)
  • Imbio LLC (US)
  • Luminex Corporation (US)
  • MedMira Inc. (Canada)
  • Meridian Bioscience, Inc. (US)
  • Nanosphere (US)
  • QIAGEN N.V. (Netherlands)
  • Thermo Fisher Scientific Inc. (US)
  • T2 Biosystems, Inc. (US)
  • Biomarck Pharmaceuticals Ltd. (UK)
  • Magnitude Biosciences (US)
  • Axis-Shield Diagnostics Ltd. (UK)
  • Biocartis Group NV (Belgium)
  • Inflammatix Inc. (US)
  • OpGen, Inc. (US)

Global Sepsis Diagnostics Market Recent Developments

  • In March 2024, Cytovale, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced new data that demonstrates how its IntelliSep® test reduced cost of care and improved efficiency of sepsis care for a large U.S. academic center.

  • In March 2024, UK diagnostics firm 52North Health announced that it is preparing to launch on the British, American, and European markets next year a test for neutropenic sepsis, a condition that often occurs in cancer patients receiving chemotherapy that can be fatal if not treated immediately.

  • In December 2023, Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced it has raised $84 million in Series C funding for transformative sepsis diagnostic tool, led by Norwest Venture Partners with participation by additional new investors Sands Capital and Global Health Investment Corporation (GHIC).

Sepsis Diagnostics Key Market Trends

  • One of the key market trends in the global sepsis diagnostic market is the increasing adoption of point-of-care (POC) testing. POC tests are designed to provide rapid and accurate diagnosis of sepsis, which can significantly improve patient outcomes. POC tests are portable, easy-to-use, and can be conducted outside the traditional laboratory setting, making them ideal for use in emergency rooms, ambulances, and critical care units. The demand for POC tests is expected to increase over the forecast period, driven by the need for rapid diagnosis and the growing adoption of digital health technologies.

Sepsis Diagnostics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global sepsis diagnostic market analysis, the market is expected to grow significantly over the forecast period, driven by several factors, including the high prevalence of sepsis, increasing awareness, and the introduction of technologically advanced diagnostic solutions. The market is highly competitive, with several established players investing heavily in R&D activities to develop innovative diagnostic solutions and gain a competitive edge. Point-of-care (POC) testing is a key market trend, with POC tests being increasingly adopted for their rapid and accurate diagnosis of sepsis. However, the high cost of diagnostic tests and the lack of skilled healthcare professionals in developing countries are expected to restrain market growth. North America is the dominating region, while the Asia-Pacific region is expected to witness the fastest growth, driven by the growing demand for rapid diagnostic solutions and the increasing prevalence of sepsis in the region.

Report Metric Details
Market size value in 2023 USD 0.67 billion
Market size value in 2031 USD 1.55 billion
Growth Rate 9.8%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Technology
    • Blood Culture Technology and Immunoassays
  • Application
    • Hospitals and Diagnostics Centres
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories (US)
  • Becton, Dickinson and Company (US)
  • bioMérieux SA (France)
  • Cepheid (US)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Hologic Inc. (US)
  • Imbio LLC (US)
  • Luminex Corporation (US)
  • MedMira Inc. (Canada)
  • Meridian Bioscience, Inc. (US)
  • Nanosphere (US)
  • QIAGEN N.V. (Netherlands)
  • Thermo Fisher Scientific Inc. (US)
  • T2 Biosystems, Inc. (US)
  • Biomarck Pharmaceuticals Ltd. (UK)
  • Magnitude Biosciences (US)
  • Axis-Shield Diagnostics Ltd. (UK)
  • Biocartis Group NV (Belgium)
  • Inflammatix Inc. (US)
  • OpGen, Inc. (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Sepsis Diagnostics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Sepsis Diagnostics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Sepsis Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Sepsis Diagnostics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Sepsis Diagnostics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Sepsis Diagnostics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Sepsis Diagnostics Market size was valued at USD 0.67 billion in 2022 and is poised to grow from USD 0.74 billion in 2023 to USD 1.55 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031). 

The sepsis diagnostic market is highly competitive, with several established players competing for market share. These companies are investing heavily in R&D activities to develop technologically advanced diagnostic solutions and gain a competitive edge. Moreover, strategic partnerships and collaborations with other companies and healthcare facilities are commonly observed in the market. Additionally, companies are focusing on expanding their geographic presence through acquisitions, partnerships, and collaborations. Furthermore, product launches, regulatory approvals, and patent filings are among the key strategies adopted by companies to strengthen their market position. 'Abbott Laboratories (US)', 'Becton, Dickinson and Company (US)', 'bioMérieux SA (France)', 'Cepheid (US)', 'F. Hoffmann-La Roche AG (Switzerland)', 'Hologic Inc. (US)', 'Imbio LLC (US)', 'Luminex Corporation (US)', 'MedMira Inc. (Canada)', 'Meridian Bioscience, Inc. (US)', 'Nanosphere (US)', 'QIAGEN N.V. (Netherlands)', 'Thermo Fisher Scientific Inc. (US)', 'T2 Biosystems, Inc. (US)', 'Biomarck Pharmaceuticals Ltd. (UK)', 'Magnitude Biosciences (US)', 'Axis-Shield Diagnostics Ltd. (UK)', 'Biocartis Group NV (Belgium)', 'Inflammatix Inc. (US)', 'OpGen, Inc. (US)'

One of the key market trends in the sepsis diagnostic market is the increasing adoption of point-of-care (POC) testing. POC tests are designed to provide rapid and accurate diagnosis of sepsis, which can significantly improve patient outcomes. POC tests are portable, easy-to-use, and can be conducted outside the traditional laboratory setting, making them ideal for use in emergency rooms, ambulances, and critical care units. The demand for POC tests is expected to increase over the forecast period, driven by the need for rapid diagnosis and the growing adoption of digital health technologies.

North America dominated the sepsis diagnostic market due to the increasing incidence of sepsis and hospital-acquired infections, coupled with the presence of leading market players and advanced healthcare infrastructure. The US and Canada are the major contributors to the growth of the market in this region. In addition, the increasing awareness about sepsis and the availability of advanced diagnostic solutions are also driving the growth of the market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Sepsis Diagnostics Market

Product ID: SQMIG35A2237

$5,300
BUY NOW GET FREE SAMPLE